AzTrials
AzTrials

Emergence DeliriumNCT06493513

The Effect of 40 Hz Transcranial Stimulation on the Incidence of Emergence Delirium in Children

A study testing 40Hz stimulation in people with Emergence Delirium and Anesthesia, run by Henan Provincial People's Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Emergence delirium is a complex of perceptual deficits and psychomotor agitation most commonly seen in preschool children in the early post-anesthetic period. It increases the risk of bed falls, accidental catheter removal, surgical wound dehiscence, and delayed discharge in children. Read more about this study

Who is it for?
Ages 3 to 14 years
Conditions the study is for
Emergence Delirium, Anesthesia, Children
What is being tested?
40Hz stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteChina
Study dates
1 Apr 2024to 6 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 3-14 years old
  • ASA classification I or II
  • Proposed vascular malformation surgery under sevoflurane general anesthesia
  • Anesthesia duration>1h
  • Obtaining informed consent

Who cannot join

  • Emergency surgery
  • Mental retardation
  • Neurological disorders with manic-like symptoms
  • Presence of severe kidney or liver disease, heart or respiratory disease
  • Autoimmune diseases
  • Vascular malformation of the head and face
  • Significant life changes in the 1 month prior to surgery

Trial locations and contacts

1 site in 1 country.

China1 site
  • Henan Provincial People's Hospital

    Zhengzhou, Henan, 450000

Other trials in China

About this study

Official title: The Effect of 40 Hz Transcranial Stimulation on the Incidence of Emergence Delirium After Sevoflurane Anesthesia in Children

Emergence delirium is a complex of perceptual deficits and psychomotor agitation most commonly seen in preschool children in the early post-anesthetic period. It increases the risk of bed falls, accidental catheter removal, surgical wound dehiscence, and delayed discharge in children. Exogenous 40 Hz stimulation can improve cognitive functioning. Therefore, the aim of this study was to explore the effect of 40Hz stimulation on the incidence of emergence delirium in children undergoing vascular malformation surgery under sevoflurane anesthesia.

Being tested
40Hz stimulation
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 40Hz stimulationDevice

    Exogenous 40Hz stimulation is a physical intervention that induces gamma oscillations, oscillations and pulsations at the corresponding frequency, and may lead to a significant reduction in β-amyloid, reversal of tau protein hyperphosphorylation, and consequently improvement of cognitive function in patients.

Study groups in NCT06493513
Study groupRoleWhat they receive
40Hz stimulation groupExperimentalAt the start of anesthesia, the child received 40Hz transcranial stimulation for 1h.
Receives: Device: 40Hz stimulation
Control groupNo interventionAt the start of anesthesia, the child did not receive any additional treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of emergence delirium

    Emergence delirium was considered to have occurred in the subject child if Pediatric Anesthesia Emergence Delirium (PAED) scale ≥10 or Cornell Assessment of Pediatric Delirium (CAPD) scale ≥10 (PAED range: 0-20 points, CAPD range: 0 ~ 32 points).

    Measured: From extubation to 2 h after extubation and day 1, day 2, day 3 after surgery.

Secondary outcomes (3)
  1. The incidence of pain

    If the Face, Legs, Activity, Cry and Consolability (FLACC) scale ≥ 4 (0 [no pain] ~ 10 [worst pain]), the child was considered to be in pain.

    Measured: Day 1, day 2, day 3 after surgery.

  2. The incidence of postoperative nausea and vomiting

    Follow up patients for nausea and vomiting

    Measured: Day 1, day 2, day 3 after surgery.

  3. Sleep quality

    Assessment of children's daily sleep quality by Self-Rating Scale of Sleep (SRSS), with a score range of 10 ~ 50, with higher scores indicating poorer sleep quality.

    Measured: Day 1, day 2, day 3 after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2024
  2. Study start1 Apr 2024
  3. Primary completion6 Aug 2024
  4. Study completion6 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental group: at the onset of anesthesia, the child received 40Hz transcranial stimulation for 1h. Control group: at the start of anesthesia, the child did not receive any additional treatment.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06493513
Sponsor's protocol ID
Henan-FSH
Status last verified
Oct 2024
First submitted
30 Jun 2024
Last updated
29 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fu S, Bian J, Fu Y, Yang Y, Wang Y, Zhu G, Ruan X, Li N, Wang D, Zhang J, Sun M. 40-Hz Light Stimulation and Emergence Delirium Incidence After Sevoflurane Anesthesia in Children: A Randomized Clinical Trial. JAMA Pediatr. 2025 Dec 1;179(12):1300-1307. doi: 10.1001/jamapediatrics.2025.3903.

    PubMed 41082242

Questions about this trial

What is this clinical trial studying?

A study testing 40Hz stimulation in people with Emergence Delirium and Anesthesia, run by Henan Provincial People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of emergence delirium (time frame: From extubation to 2 h after extubation and day 1, day 2, day 3 after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06493513, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in